HPV vaccine: Cervarix
- 8 January 2010
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Biological Therapy
- Vol. 10 (3) , 477-487
- https://doi.org/10.1517/14712591003601944
Abstract
(2010). HPV vaccine: Cervarix. Expert Opinion on Biological Therapy: Vol. 10, No. 3, pp. 477-487. doi: 10.1517/14712591003601944Keywords
This publication has 68 references indexed in Scilit:
- Immunogenicity Testing in Human Papillomavirus Virus‐Like‐Particle Vaccine TrialsThe Journal of Infectious Diseases, 2009
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young womenPublished by Elsevier ,2009
- Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccinesVaccine, 2008
- An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial resultsVaccine, 2008
- Persistent Human Papillomavirus Infection and Cervical Neoplasia: A Systematic Review and Meta-AnalysisAmerican Journal of Epidemiology, 2008
- Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screeningBritish Journal of Cancer, 2008
- HPV and cervical cancer: screening or vaccination?British Journal of Cancer, 2008
- High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-upBritish Journal of Cancer, 2006
- The cervical cancer epidemic that screening has prevented in the UKThe Lancet, 2004
- The Rising Incidence of Adenocarcinoma Relative to Squamous Cell Carcinoma of the Uterine Cervix in the United States—A 24-Year Population-Based StudyGynecologic Oncology, 2000